Figure 4From: Validation of cytoplasmic-to-nuclear ratio of survivin as an indicator of improved prognosis in breast cancer Increased nuclear survivin predicts outcome in ER-positive patients. Kaplan-Meier estimation of OS and BCSS in ER-positive, tamoxifen treated patients stratified according to (A) CNR and (B) SNAS.Back to article page